Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Micromachines
|
July 8, 2023
A Deep Learning Approach for Predicting Multiple Sclerosis
Edgar Rafael Ponce de Leon-Sanchez, Omar Arturo Dominguez-Ramirez, Ana Marcela Herrera-Navarro, et al.
Revista Da Sociedade Brasileira De Medicina Tropical
|
March 8, 2021
Antimicrobial-resistant enterobacteria in surface waters with fecal contamination from urban and rural communities
Vanessa Tibolla Moretto, Soraia Machado Cordeiro, Patricia Salcedo Bartley, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Antibiotic Resistance in Enterobacteriaceae from Surface Waters in Urban Brazil Highlights the Risks of Poor Sanitation
Patricia S Bartley, T Nicholas Domitrovic, Vanessa T Moretto, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 5, 2008
Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept
Michela Carbonatto, Ping Yu, Mauro Bertolino, et al.
Journal of Environmental Radioactivity
|
June 20, 2026
Baseline radon concentrations in uranium-rich and faulted zones of the Eastern Cordillera, Central Andes, Peru
Briant García Fernández-Baca, César J Guevara-Pillaca, Víctor Viera, et al.
The Journal of Nutrition
|
March 30, 2005
Dietary intakes vary with age among Eskimo adults of Northwest Alaska in the GOCADAN study, 2000-2003
Elizabeth D Nobmann, Rafael Ponce, Claudia Mattil, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 4, 2020
Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib
Jim S Qin, Timothy G Johnstone, Alex Baturevych, et al.
Bioengineering (Basel, Switzerland)
|
May 27, 2026
Artificial Intelligence Algorithm Based on Genetics to Predict Responses to Interferon-Beta Treatment in Multiple Sclerosis Patients
Edgar Rafael Ponce de León-Sánchez, Jorge Domingo Mendiola-Santibañez, Omar Arturo Domínguez-Ramírez, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 7, 2009
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies
Rafael Ponce, Leslie Abad, Lakshmi Amaravadi, et al.
International Journal for Parasitology
|
March 9, 2016
Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission
Lúcio M Barbosa, Eliana A Reis, Cláudio R A Dos Santos, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Micromachines
|
July 8, 2023
A Deep Learning Approach for Predicting Multiple Sclerosis
Edgar Rafael Ponce de Leon-Sanchez, Omar Arturo Dominguez-Ramirez, Ana Marcela Herrera-Navarro, et al.
Revista Da Sociedade Brasileira De Medicina Tropical
|
March 8, 2021
Antimicrobial-resistant enterobacteria in surface waters with fecal contamination from urban and rural communities
Vanessa Tibolla Moretto, Soraia Machado Cordeiro, Patricia Salcedo Bartley, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Antibiotic Resistance in Enterobacteriaceae from Surface Waters in Urban Brazil Highlights the Risks of Poor Sanitation
Patricia S Bartley, T Nicholas Domitrovic, Vanessa T Moretto, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
June 5, 2008
Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept
Michela Carbonatto, Ping Yu, Mauro Bertolino, et al.
Journal of Environmental Radioactivity
|
June 20, 2026
Baseline radon concentrations in uranium-rich and faulted zones of the Eastern Cordillera, Central Andes, Peru
Briant García Fernández-Baca, César J Guevara-Pillaca, Víctor Viera, et al.
The Journal of Nutrition
|
March 30, 2005
Dietary intakes vary with age among Eskimo adults of Northwest Alaska in the GOCADAN study, 2000-2003
Elizabeth D Nobmann, Rafael Ponce, Claudia Mattil, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 4, 2020
Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib
Jim S Qin, Timothy G Johnstone, Alex Baturevych, et al.
Bioengineering (Basel, Switzerland)
|
May 27, 2026
Artificial Intelligence Algorithm Based on Genetics to Predict Responses to Interferon-Beta Treatment in Multiple Sclerosis Patients
Edgar Rafael Ponce de León-Sánchez, Jorge Domingo Mendiola-Santibañez, Omar Arturo Domínguez-Ramírez, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 7, 2009
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies
Rafael Ponce, Leslie Abad, Lakshmi Amaravadi, et al.
International Journal for Parasitology
|
March 9, 2016
Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission
Lúcio M Barbosa, Eliana A Reis, Cláudio R A Dos Santos, et al.
Page
of 4